Drug reference
sofpironium
Muscarinic antagonist · Anticholinergic
Muscarinic antagonistAnticholinergic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Reduces sweating locally by inhibiting M3 receptors at eccrine sweat glands.
Indications
Primary axillary hyperhidrosis (topical gel, approved in Japan)
Related guidelines
Other Muscarinic antagonist drugs
Ask House about sofpironium
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team